News & Perspective
Drugs & Diseases
CME & Education
Academy
Video
Decision Point

Specialty: Multispecialty
Allergy & Immunology
Anesthesiology
Cardiology
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Medicine
Gastroenterology
General Surgery
Hematology - Oncology
HIV/AIDS
Hospital Medicine
Infectious Diseases
Internal Medicine
Multispecialty
Nephrology
Neurology
Ob/Gyn & Women's Health
Oncology
Ophthalmology
Orthopedics
Pathology & Lab Medicine
Pediatrics
Plastic Surgery
Psychiatry
Public Health
Pulmonary Medicine
Radiology
Rheumatology
Transplantation
Urology
Today on Medscape
Business of Medicine
Medical Lifestyle
Science & Technology
Medical Students
Nurses
Pharmacists
Residents
Edition: English

Medscape

English
Deutsch
Español
Français
Português
UKNew

Univadis

Sign Up It's Free!
English Edition

Medscape

Univadis

    X
    Univadis from Medscape

    No Results

      Wednesday, February 1, 2023
      News & Perspective Drugs & Diseases CME & Education Academy Video Decision Point

      From Medscape Pulmonary Medicine

      Coverage from the

      CHEST 2017: American College of Chest Physicians Annual Meeting

      October 28 - November 01, 2017; Toronto, Canada

      October 28 - November 01, 2017 Toronto, Canada

      Conference News

      Popular News From CHEST 2016

      • New Inhaled Antibiotic Promising in Bronchiectasis New Inhaled Antibiotic Promising in Bronchiectasis An inhaled powder form of ciprofloxacin is effective for patients with non-cystic fibrosis bronchiectasis, an orphan disease with no approved treatments, results from a phase 3 suggest.
        Medscape Medical News, Oct 28, 2016
      • Bedside Imaging Can Gauge Dysfunction in Pulmonary Embolism Bedside Imaging Can Gauge Dysfunction in Pulmonary Embolism Point-of-care ultrasound can be used by fellows to triage patients with acute pulmonary embolism easily and quickly, without sacrificing accuracy, new research shows, but not everyone agrees.
        Medscape Medical News, Oct 31, 2016
      • Benefit of Antifibrotics in Pulmonary Fibrosis Debated Benefit of Antifibrotics in Pulmonary Fibrosis Debated Patients with pulmonary fibrosis appear to be helped by antifibrotic treatment, irrespective of disease severity, report investigators of four post hoc exploratory analyses, but more study is needed.
        Medscape Medical News, Oct 27, 2016

      Medscape Pulmonary Medicine©  WebMD, LLC

      Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

      Previous Coverage

      Find Us On
      About
      About Medscape Privacy Policy Editorial Policy Cookies Terms of Use Advertising Policy Help Center
      Membership
      Become a Member About You Professional Information Newsletters & Alerts Market Research
      App
      Medscape
      WebMD Network
      Medscape Live Events WebMD MedicineNet eMedicineHealth RxList WebMD Corporate Medscape UK
      Editions
      English Deutsch Español Français Português UK
      All material on this website is protected by copyright, Copyright © 1994-2023 by WebMD LLC. This website also contains material copyrighted by 3rd parties.